Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease

Atherosclerosis

Volumn 242, Issue 1, 2015, Pages 37-44

[No Author Info available]

Author keywords

Atheromatous disease; Carotid ultrasound; Diabetic nephropathy

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERRITIN; HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ANTICOAGULANT THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROMA; ATHEROMATOUS DISEASE; ATHEROSCLEROTIC PLAQUE; B SCAN; BODY MASS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FERRITIN BLOOD LEVEL; GENDER; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VASCULAR NEPHROPATHY; ADOLESCENT; ASYMPTOMATIC DISEASE; CAROTID STENOSIS; CLINICAL TRIAL; COMORBIDITY; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; ECHOGRAPHY; HYPERLIPIDEMIAS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OBESITY; PLAQUE, ATHEROSCLEROTIC; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPAIN; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANKLE BRACHIAL INDEX; ASYMPTOMATIC DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CAROTID STENOSIS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SPAIN; YOUNG ADULT;

EID: 84936972056     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.06.048     Document Type: Article

References (31)

1. Matsushita K., van der Velde M., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375:2073-2081. Chronic Kidney Disease Prognosis, C.
2. Herzog C.A., Asinger R.W., Berger A.K., et al. Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011, 80:572-586.
3. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N.Engl. J. Med. 2004, 351:1296-1305.
4. Baigent C., Landray M.J., Reith C., et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 2011, 377:2181-2192.
5. Ridker P.M., Group J.S. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 2003, 108:2292-2297.
6. Mann J.F., Gerstein H.C., Pogue J., et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann. Intern Med. 2001, 134:629-636.
7. Coll B., Betriu A., Martinez-Alonso M., et al. Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment. Nephrol. Dial. Transpl. 2010, 25:3017-3025.
8. Komorovsky R., Desideri A. Carotid ultrasound assessment of patients with coronary artery disease: a useful index for risk stratification. Vasc. Health Risk Manag. 2005, 1:131-136.
9. Betriu A., Martinez-Alonso M., Arcidiacono M.V., et al. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study. Nephrol. Dial. Transpl. Jul 2014, 29(7):1415-1422.
10. Arroyo D., Betriu A., Martinez-Alonso M., et al. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study. BMC Nephrol. 2014, 15:168.
11. Ichihara A., Yamashita N., Takemitsu T., et al. Cardio-ankle vascular index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis. Am. J. Kidney Dis. 2008, 52:947-955.
12. Blacher J., Guerin A.P., Pannier B., et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001, 38:938-942.
13. Andrassy K.M. Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease'. Kidney Int. 2013, 84:622-623.
14. Jovanovic D.B., Djukanovic L. Analysis of factors influencing chronic renal failure progression. Ren. Fail 1999, 21:177-187.
15. Haynes R., Staplin N., Emberson J., et al. Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the study of heart and renal protection (SHARP). Am. J. Kidney Dis. Jul 2014, 64(1):40-48.
16. Betriu-Bars A., Fernandez-Giraldez E. Carotid ultrasound for the early diagnosis of atherosclerosis in chronic kidney disease. Nefrologia 2012, 32:7-11.
17. Junyent M., Martinez M., Borras M., et al. Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study. BMC Nephrol. 2010, 11:14.
18. Junyent M., Gilabert R., Nunez I., et al. Carotid ultrasound in the assessment of preclinical atherosclerosis. Distribution of intima-media thickness values and plaque frequency in a Spanish community cohort. Med. Clin. Barc. 2005, 125:770-774.
19. Junyent M., Martinez M., Borras M., et al. Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: the NEFRONA project. Nefrologia 2010, 30:119-126.
20. Hoogwerf B.J. Renin-angiotensin system blockade and cardiovascular and renal protection. Am. J. Cardiol. 2010, 105:30A-35A.
21. Utsunomiya K. Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance. Vasc. Health Risk Manag. 2012, 8:429-436.
22. Palmer S.C., Navaneethan S.D., Craig J.C., et al. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst. Rev. 2013, 9:CD004289.
23. Hemmelgarn B.R., Manns B.J., Lloyd A., et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010, 303:423-429.
24. Abe M., Okada K., Soma M. Mineral metabolic abnormalities and mortality in dialysis patients. Nutrients 2013, 5:1002-1023.
25. Huang C., Shapses S.A., Wang X. Association of plasma parathyroid hormone with metabolic syndrome and risk for cardiovascular disease. Endocr. Pract. Official J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 2013, 19:712-717.
26. Tonelli M., Muntner P., Lloyd A., et al. Association between LDL-C and risk of myocardial infarction in CKD. J.Am. Soc. Nephrol. JASN 2013, 24:979-986.
27. Elliott M.K., McCaughan J.A., Fogarty D.G. Do patients with chronic kidney disease get optimal cardiovascular risk reduction?. Curr. Opin. Nephrol. Hypertens. 2014, 23:267-274.
28. Gonzalez A.S., Guerrero D.B., Soto M.B., et al. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur. J. Clin. Nutr. 2006, 60:802-809.
29. Sung K.C., Kang S.M., Cho E.J., et al. Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2525-2530.
30. Libby P., Tabas I., Fredman G., et al. Inflammation and its resolution as determinants of acute coronary syndromes. Circulation Res. 2014, 114:1867-1879.
31. Tonelli M., Riella M.C. Chronic kidney disease: chronic kidney disease and the ageing population. Nat. Rev. Nephrol. 2014, 10:127-128.